货号:A165209 同义名: CS-3150;XL-550
Esaxerenone is an aldosterone receptor antagonist. Esaxerenone may be potential useful for preventing or treating hypertension or disease caused by hypertension.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Esaxerenone is recognized as a highly effective and selective antagonist for the non-steroidal mineralocorticoid receptor[1]. |
Animal study | Following a single oral dose of Esaxerenone at 0.1, 0.3, 1, and 3 mg/kg, there is a dose-dependent increase in both the maximum plasma concentration (Cmax) and the area under the plasma concentration-time curve (AUC). The Tmax, or the time to reach Cmax, varies from 2.0 to 4.5 hours. With intravenous doses of Esaxerenone at the same concentrations, the total body clearance (CL) ranges from 3.53 to 6.69 mL/min/kg and the steady-state distribution volume (Vss) from 1.47 to 2.49 L/kg in rats, while in cynomolgus monkeys, the CL is 2.79 to 3.69 mL/min/kg and the Vss is 1.34 to 1.54 L/kg. Post-administration, up to 168 hours, rats excrete 3.9% of the radioactivity in urine and 91.4% in feces, totaling 95.2%. In monkeys, 11.5% is excreted in urine, 82.3% in feces, and 93.9% in total within the same timeframe[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.14mL 0.43mL 0.21mL |
10.72mL 2.14mL 1.07mL |
21.44mL 4.29mL 2.14mL |
CAS号 | 1632006-28-0 |
分子式 | C22H21F3N2O4S |
分子量 | 466.473 |
别名 | CS-3150;XL-550 |
运输 | 蓝冰 |
存储条件 |
粉末 Sealed in dry,2-8°C 液体 -20°C:3-6个月-80°C:12个月 |
溶解度 |
DMSO: 105 mg/mL(225.09 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |